Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

1.88%

7.9¢ percheron therapeutics limited

Chart, page-4331

First 4331 Last

Share
Profile

Follow
sorest2016

445 Posts.

75

27/10/21

19:29

Post #: 57124116
Share

Originally posted by shyaam1996: ↑

I mean they could go alone, but it’s incredibly risky. The PRV would likely go for 80-100M USD which would cover their P2B EMA + Dual FDA preclin/clin trials, but likely would dry up and not cover the later phase 2 trials for the FDA. I doubt ANP management want to try and tackle these pipelines by themselves, but I could be wrong.0

Expand

Don't they get the PRV after They have been FDA approved for use? They would have to fund the trial first.

ANP Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

There are more pages in this discussion • 1,575 more messages in this thread...

First 4331 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.9¢		Change -0.002(1.88%)		Mkt cap ! $70.77M

Open	High	Low	Value	Volume
8.0¢	8.2¢	7.8¢	$66.20K	831.8K

Buyers (Bids)

No.	Vol.	Price($)
3	216590	7.7¢

Sellers (Offers)

Price($)	Vol.	No.
7.9¢	24573	1

View Market Depth

No.	Vol.	Price($)
3	216590	0.077
2	66500	0.076
4	206988	0.075
2	353708	0.074
2	87000	0.072

Price($)	Vol.	No.
0.079	24573	1
0.080	299770	2
0.082	255785	2
0.083	134797	3
0.084	157142	2

Last trade - 15.45pm 17/07/2024 (20 minute delay)

PER (ASX) Chart